Filing Details
- Accession Number:
- 0001104659-20-086423
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-24 16:05:45
- Reporting Period:
- 2020-07-22
- Accepted Time:
- 2020-07-24 16:05:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 895051 | Casi Pharmaceuticals Inc. | CASI | Biological Products, (No Disgnostic Substances) (2836) | 581959440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1754903 | Larry Zhang | Casi Pharmaceuticals, Inc. 9620 Medical Center Drive, Suite 300 Rockville MD 20850 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-22 | 20,153 | $1.90 | 20,153 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
